Selectis Health (GBCS) Stock Price, News & Analysis

Company Overview

Selectis Health Corporation (OTCMKTS: GBCS) is a U.S.-based specialty healthcare company focused on the research, development and commercialization of proprietary medical technologies and consumer health products. The company develops and markets advanced wound care dressings, orthopedic regenerative implants and novel nutraceutical formulations. Selectis Health’s product portfolio includes scaffold-based healing matrices, bioactive joint support supplements and a range of topical and oral therapeutic agents designed to support tissue regeneration and overall wellness.

Founded in 2012 and headquartered in Miami, Florida, Selectis Health has expanded its operations to serve key markets across North America, Europe and Asia. The company’s manufacturing facilities adhere to current Good Manufacturing Practice (cGMP) standards, and it leverages strategic partnerships to enhance its supply chain, distribution network and regulatory compliance. Over the years, Selectis Health has secured several patents and trademarks for its proprietary biomaterials and delivery systems.

In addition to its core product lines, Selectis Health operates a research and development center focused on emerging regenerative medicine applications, including cellular therapies and 3D-bioprinting technologies. The company’s R&D pipeline encompasses next-generation wound closure devices, orthopedic cartilage scaffolds and synergies with digital health platforms for remote patient monitoring. Selectis Health also offers contract manufacturing services for select partners seeking cGMP-certified production of medical-grade products.

Selectis Health is led by a management team with deep industry experience. John P. Richards serves as President and Chief Executive Officer, bringing over 25 years of leadership in medical device commercialization. Chief Scientific Officer Dr. Maria L. Ortega oversees the company’s R&D efforts, while Chief Financial Officer Peter Zhao manages financial planning and investor relations. The board includes a mix of healthcare veterans and life sciences investors, positioning the company for strategic growth as it advances its product pipeline.

Key Stats

• Today's Range: $2.51 to $3.00
• 50-Day Range: $1.51 to $2.55
• 52-Week Range: $0.41 to $4.50
• Volume: 666 shs
• Average Volume: 508 shs
• Market Capitalization: $7.83 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GBCS Stock Analysis - Frequently Asked Questions

How have GBCS shares performed this year?

Selectis Health's stock was trading at $1.12 at the beginning of 2025. Since then, GBCS shares have increased by 127.7% and is now trading at $2.55.

How were Selectis Health's earnings last quarter?

Selectis Health, Inc. (OTCMKTS:GBCS) posted its earnings results on Tuesday, May, 20th. The company reported ($0.22) earnings per share (EPS) for the quarter. The firm had revenue of $10.49 million for the quarter.

When did Selectis Health's stock split?

Selectis Health shares reverse split on Wednesday, September 22nd 2021.The 1-10 reverse split was announced on Wednesday, September 22nd 2021. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, September 22nd 2021. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Selectis Health?

Shares of GBCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Selectis Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Selectis Health investors own include Chemed (CHE), Walt Disney (DIS), OceanFirst Financial (OCFC), Celanese (CE), Credit Acceptance (CACC), Blackstone Mortgage Trust (BXMT) and Blackstone (BX).

Company Calendar

• Last Earnings: 5/20/2025
• Today: 7/12/2025
• Next Earnings (Estimated): 8/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Trading
• Current Symbol: OTCMKTS:GBCS
• CIK: 727346
• Web: www.gbcsreit.com
• Phone: (720) 680-0808
• Fax: 303-527-2916
• Employees: 500
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.67)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.42 million
• Net Margins: -5.07%
• Pretax Margin: -5.05%
• Return on Equity: N/A
• Return on Assets: -5.92%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.22
• Quick Ratio: 0.22

Sales & Book Value

• Annual Sales: $39.49 million
• Price / Sales: 0.20
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($2.02) per share
• Price / Book: -1.26

Miscellaneous

• Outstanding Shares: 3,070,000
• Free Float: 2,601,000
• Market Cap: $7.83 million
• Optionable: Not Optionable
• Beta: -0.40